Orthocell Statistics

Total Valuation

Orthocell has a market cap or net worth of AUD 377.92 million. The enterprise value is 347.73 million.

Market Cap	377.92M
Enterprise Value	347.73M

Important Dates

The next estimated earnings date is Friday, May 23, 2025.

Earnings Date	May 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Orthocell has 239.95 million shares outstanding. The number of shares has increased by 4.09% in one year.

Current Share Class	n/a
Shares Outstanding	239.95M
Shares Change (YoY)	+4.09%
Shares Change (QoQ)	+6.48%
Owned by Insiders (%)	20.58%
Owned by Institutions (%)	2.01%
Float	189.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	52.24
PB Ratio	19.22
P/TBV Ratio	20.32
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-107.09
EV / Sales	55.06
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-43.12

Financial Position

The company has a current ratio of 7.53, with a Debt / Equity ratio of 0.03.

Current Ratio	7.53
Quick Ratio	7.30
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.08
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -29.77% and return on invested capital (ROIC) is -56.81%.

Return on Equity (ROE)	-29.77%
Return on Assets (ROA)	-20.32%
Return on Invested Capital (ROIC)	-56.81%
Return on Capital Employed (ROCE)	-30.01%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.19
Inventory Turnover	1.92

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +306.98% in the last 52 weeks. The beta is 0.54, so Orthocell's price volatility has been lower than the market average.

Beta (5Y)	0.54
52-Week Price Change	+306.98%
50-Day Moving Average	1.45
200-Day Moving Average	0.84
Relative Strength Index (RSI)	60.25
Average Volume (20 Days)	1,503,300

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Orthocell had revenue of AUD 6.31 million and -3.25 million in losses. Loss per share was -0.02.

Revenue	6.31M
Gross Profit	4.23M
Operating Income	-10.56M
Pretax Income	-9.48M
Net Income	-3.25M
EBITDA	-10.18M
EBIT	-10.56M
Loss Per Share	-0.02

Full Income Statement

Balance Sheet

The company has 30.84 million in cash and 657,928 in debt, giving a net cash position of 30.18 million or 0.13 per share.

Cash & Cash Equivalents	30.84M
Total Debt	657,928
Net Cash	30.18M
Net Cash Per Share	0.13
Equity (Book Value)	19.64M
Book Value Per Share	0.08
Working Capital	31.70M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.34 million and capital expenditures -725,055, giving a free cash flow of -8.06 million.

Operating Cash Flow	-7.34M
Capital Expenditures	-725,055
Free Cash Flow	-8.06M
FCF Per Share	-0.03

Full Cash Flow Statement

Margins

Gross margin is 67.04%, with operating and profit margins of -167.21% and -51.42%.

Gross Margin	67.04%
Operating Margin	-167.21%
Pretax Margin	-150.17%
Profit Margin	-51.42%
EBITDA Margin	-161.18%
EBIT Margin	-167.21%
FCF Margin	n/a

Dividends & Yields

Orthocell does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.09%
Shareholder Yield	-4.09%
Earnings Yield	-0.86%
FCF Yield	-2.13%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Orthocell has an Altman Z-Score of 1.03. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.03
Piotroski F-Score	n/a